Abstract: Techniques for generating a workflow diagram automatically from code are described herein. The diagram can be generated in real-time with code changes or as a batch-processing operation to generate drawings as documentation. An extent delineator is identified in the source code. Based on the location of that extent delineator, a determination is made that multiple lines of the source code share a relationship with one another. An extent is formed by grouping those lines together. An AST, which is based on the code, is accessed. Multiple AST nodes are identified. These nodes correspond to the extent. A flowchart is generated based on (i) the AST, (ii) the source code, and (iii) the extent delineator. One of the flowchart nodes commonly represents the multiple AST nodes corresponding to the extent. This flowchart node is annotated with text that generally describes that node's logic.

Abstract: This disclosure presents a MITLIF procedure. The procedure uses a single incision on one side and pedicle screws are placed on that side and through the same incision a facet screw is placed on the opposite side using a series of jigs, and, for example, the hole cutter, drill, guide shaft and screw driver described herein.

Abstract: This disclosure presents a MITLIF procedure. The procedure uses a single incision on one side and pedicle screws are placed on that side and through the same incision a facet screw is placed on the opposite side using a series of jigs, and, for example, the hole cutter, drill, guide shaft and screw driver described herein.

Abstract: Methods, systems, computer program products and data structures are described which allow for efficient correction of a transcription output of an automatic speech recognition system by a human proofreader. A method comprises receiving a voice input from a user; determining a transcription of the voice input; providing the transcription of the voice input; receiving a text input from the user indicating a revision to the transcription; determining how to revise the transcription in accordance with the text input; and revising the transcription of the voice input in accordance with the text input. A general or specialized language model, an acoustical language model, a character language model, a gaze tracker, and/or a stylus may be used to determine how to revise the transcription in accordance with the text input.

Abstract: A refilling device for an article of an aerosol provision system comprises refilling control circuitry configured to facilitate the transfer of aerosol-generating material from a reservoir to the article in response to detecting that the article has been received by the refilling device.

Abstract: A desktop refilling device for an article of an aerosol provision system comprises an article interface configured to receive the article, a reservoir interface configured to receive a reservoir, and refilling control circuitry configured to facilitate the transfer of aerosol-generating material from the reservoir to the article, wherein the article interface and/or the reservoir interface are configured to respectively enclose the article and the reservoir inside a housing of the desktop refilling device during the transfer of aerosol-generating material from the reservoir to the article.

Abstract: A desktop refilling device for an article of an aerosol provision system comprising the article and an aerosol provision device. The desktop refilling device comprises an article interface configured to receive the article when the article is separated from the aerosol provision device, and refilling control circuitry configured to facilitate the transfer of aerosol-generating material from a reservoir couplable to the refilling device to the article.

Abstract: The present disclosure relates to a method of preventing or treating a cancer via administering an EHMT2 inhibitor or a combination comprising an EHMT2 inhibitor compound and one or more additional therapeutic agent disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds or combinations for research or other non-therapeutic purposes.

Abstract: The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Abstract: A method, system, apparatus and computer program product are disclosed for enhancing operable functionality of xAPI statements by sequentially comparing a plurality of authorized xAPI statements against a plurality of trigger rules with a pattern matching process which evaluates matching xAPI data properties and logical and/or comparative operator requirements from each trigger rule against each authorized xAPI statement to identify matching trigger rules which are evaluated against one or more required trigger rules associated with a first trigger to automatically generate one or more outbound REST API calls to communicate with a third-party application upon detecting that the all the required trigger rules associated with the first trigger are matched by an actor.

Abstract: The is provided a computer-implemented method for generating a quantum circuit from a Unitary Coupled Cluster (UCC) Ansatz, wherein the Ansatz represents an excitation of a reference state by a parameterised operator including excitation operators, and wherein the Ansatz includes multi-qubit Pauli operators that are determined from each excitation operator. The method comprises: partitioning the Pauli operators into mutually commuting sets and sequencing the Pauli operators by set; generating Pauli gadgets from the Pauli operators by Trotterization, wherein the Pauli gadgets have a same sequencing by set as the Pauli operators; diagonalising each set of Pauli gadgets to convert the Pauli gadgets into phase gadgets; and transforming the phase gadgets into one- and two-qubit native gates to generate the quantum circuit. Moreover, there is also provided a system that is configured to implement the method.

Abstract: The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Abstract: The present disclosure relates to a method of preventing or treating a cancer via administering an EHMT2 inhibitor or a combination comprising an EHMT2 inhibitor compound and one or more additional therapeutic agent disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds or combinations for research or other non-therapeutic purposes.

Abstract: The present disclosure relates to a method of preventing or treating an imprinting disorder via administering an EHMT2 inhibitor compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: In non-limiting examples of the present disclosure, systems, methods and devices for integrating speech-to-text transcription in a productivity application are presented. A request to access a real-time speech-to-text transcription of an audio signal that is being received by a second device is sent by a first device. The real-time speech-to-text transcription may be surfaced in a transcription pane of a productivity application on the first device. A request to translate the transcription to a different language may be received. The transcription may be translated in real-time and surfaced in the transcription pane. A selection of a word in the surfaced transcription may be received. A request to drag the word from the transcription pane and drop it in a window in the productivity application outside of the transcription pane may be received. The word may be surfaced in the window in the productivity application outside of the transcription pane.

Abstract: This disclosure generally relates to pyridine-2-one compounds of formula (I) and methods of using them in the treatment of a disorder, such as cancer or a SMARCA2-associated disorder, including as antagonists (e.g., inhibitors) of SMARCA2. The present disclosure provides treatment modalities, e.g., strategies, treatment methods, patient stratification methods, compounds, combinations, and compositions that are useful for the treatment of disorders, e.g., proliferative disorders, such as certain cancers. Some aspects of this disclosure provide treatment modalities, methods, strategies, compounds, compositions, combinations, and dosage forms for the treatment of cell proliferative disorders, e.g., cancers with decreased activity or function, or loss of function, of SMARCA4 with a SMARCA2 antagonist.

Abstract: The present disclosure relates to amine-substituted heterocyclic compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., cancer) by administering an amine-substituted heterocyclic heterocyclic compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present disclosure relates to substituted fused bi- or tri-heterocyclic compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., sickle cell anemia) via inhibition of a methyltransferase enzyme selected from EHMT1 and EHMT2, by administering a substituted fused bi- or tri-heterocyclic compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: In non-limiting examples of the present disclosure, systems, methods and devices for integrating speech-to-text transcription in a productivity application are presented. A request to access a real-time speech-to-text transcription of an audio signal that is being received by a second device is sent by a first device. The real-time speech-to-text transcription may be surfaced in a transcription pane of a productivity application on the first device. A request to translate the transcription to a different language may be received. The transcription may be translated in real-time and surfaced in the transcription pane. A selection of a word in the surfaced transcription may be received. A request to drag the word from the transcription pane and drop it in a window in the productivity application outside of the transcription pane may be received. The word may be surfaced in the window in the productivity application outside of the transcription pane.

Abstract: The present disclosure relates to amine-substituted heterocyclic compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., cancer) via inhibition of a methyltransferase enzyme selected from EHMT1 and EHMT2, by administering an amine-substituted heterocyclic heterocyclic compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.